Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view

B. Kakulas,F. V. van Bockxmeer
DOI: https://doi.org/10.1002/ana.410380624
IF: 11.2
1995-12-01
Annals of Neurology
Abstract:drome, with mild parkinsonism and pyramidal and anterior horn cell signs, together with mild urinary disturbance, and ha5 progressed to develop urinary incontinence. The exclusion of these 2 patients would not alter the statistical analysis. We know that many patients with cerebellar degeneration may only develop structural imaging evidence of cerebellar or brainstem atrophy after a number of years of disease; also that many patients with pathological OPCA may not show cerebellar atrophy on imaging, or even cerebellar signs during life [2]. Therefore, we prefer to base a possible or probable diagnosis of MSA on clinical grounds, rather than on structural imaging. The nosology of idiopathic late-onset cerebellar ataxia (ILOCA) is controversial. Some patients with pathology restricted to cerebellum and olives have only cerebellar signs in life and are often called cerebellar cortical atrophy (CCA). At the other extreme are patients whose brains show the pathology of OPCA, often with additional striatonigral degeneration, and contain oligodendroglial cytoplasmic inclusions [3] characteristic of MSA, and who in life had a cerebellar syndrome with additional autonomic failure, with or without parkinsonism or pyramidal signs. These are, therefore, examples of the OPCA variant of MSA. We agree with Coplin and Bird that not all sporadic OPCA cases necessarily have MSA. Whether the additional presence of pyramidal or extrapyramidal signs, or imaging evidence of brainstem atrophy {4], indicates OPCA as opposed to CCA, and what proportion of such cases will develop the autonomic failure characteristic of MSA, is currently unknown. In the present state of uncertainty, we nevertheless feel that when autonomic failure supervenes upon ILOCA (as it has in all our 10 patients) the pathological changes of OPCA, together with oligodendroglial inclusions, are very likely to be found in the brain. The majority of these brains will also show striatonigral degeneration. Sometimes this is evident clinically, but our study suggests that, even when subclinical, striatonigral degeneration may nevertheless be detectable in many of these patients using [‘8F]fluorodopa and [“C)diprenorphine PET scans.
What problem does this paper attempt to address?